Sw. Halvorsen et al., CILIARY NEUROTROPHIC FACTOR REGULATES NICOTINIC ACETYLCHOLINE-RECEPTORS ON HUMAN NEUROBLASTOMA-CELLS, Neuropharmacology, 35(3), 1996, pp. 257-265
We have investigated the effects of several neurokine/cytokine family
members on the level of alpha-bungarotoxin-binding to neuronal nicotin
ic acetylcholine receptors. Exposure of human neuroblastoma cells (SH-
SY5Y and IMR-32) to ciliary neurotrophic factor (CNTF), leukemia inhib
itory factor or oncostatin-M resulted in a 30-40% decline in alpha-bun
garotoxin receptors on the cells with no decrease seen in either musca
rinic acetylcholine receptors or in L-type Ca2+ channels. The level of
nicotinic receptor was not affected by the related cytokine, interleu
kin-6. Treatment of IMR-32 cells with 40 pM CNTF produced a half-maxim
al decrease of alpha-bungarotoxin binding which compared well with the
affinity estimated from binding of I-125- CNTF (K-i approximate to 40
pM) and the concentration causing c-fos activation in SH-SY5Y cells,
as detected by nuclear run-on assays (60-120 pM). Previous results hav
e indicated that the differentiating agents, phorbol esters and retino
ic acid, also decrease nicotinic receptor numbers. Here the effects of
CNTF, which did not induce neural differentiation, were enhanced by d
ifferentiation with 12-O-tetradecanoylphorbol 13-acetate (10 nM) and p
revented by retinoic acid (10 mu M). Therefore, the response of neurob
lastoma cells to cytokines may be under developmental control. These c
ells offer a system to examine cytokine responses and signal transduct
ion mechanisms during neural development. Copyright (C) 1996 Elsevier
Science Ltd.